ALLY

Ally Financial Inc.

69
Fundamentals77/ 100
Valuation59/ 100
Upside potential76/ 100
Risk potential12/ 100

ALLY has the edge over BAC overall, supported by stronger fundamentals and stronger modeled upside.

BAC

Bank of America Corporation

60
Fundamentals72/ 100
Valuation55/ 100
Upside potential71/ 100
Risk potential10/ 100

BAC has slightly lower modeled downside risk, despite its lower overall score.

ALLY Fundamentals

MetricStatus
Stable
Strong
N/A
N/A

ALLY's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ALLY.

BAC Fundamentals

MetricStatus
Healthy
Strong
N/A
N/A

BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.

ALLY PE Valuation

CHEAPFAIREXPENSIVE7.9x16x24x32x
CHEAPFAIREXPENSIVE7.9x16x24x32x
LevelPEPriceVs current
Cheap5.4x$23.66-38%
Forward6.5x$38.00—
Current8.7x$38.00—
Fair9.4x$41.09+8.1%
Expensive17x$75.07+98%

Historical ranges are pointers, not guarantees.

ALLY's PE is in its fair range at 8.7x. If earnings grow as analysts expect, today's price would be 6.5x next year's earnings, in its cheap range.

BAC PE Valuation

CHEAPFAIREXPENSIVE5.6x11x17x22x
CHEAPFAIREXPENSIVE5.6x11x17x22x
LevelPEPriceVs current
Cheap9.4x$39.50-22%
Forward10x$50.51—
Current12x$50.51—
Fair13x$53.81+6.5%
Expensive15x$62.23+23%

Historical ranges are pointers, not guarantees.

BAC has the edge over ALLY in the historical PE scenario, which offers more potential upside but is not a forecast.

ALLY Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for ALLY, with profitability improving.

BAC Forward outlook

MetricOutlook
Improving
Growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for BAC, with profitability improving.

ALLY Risk to reward

ScenarioChangePrice
Upside+38%$52.29
Downside-12%$33.60

Calculated from the latest close: $38.00 on Nov 12.

ALLY has a better modeled risk to reward balance than BAC, with more potential upside relative to its potential downside.

BAC Risk to reward

ScenarioChangePrice
Upside+25%$63.36
Downside-10%$45.36

Calculated from the latest close: $50.51 on Nov 12.

BAC trails ALLY on modeled risk to reward, with less potential upside relative to its potential downside.

ALLY Earnings Per Share

Q4 2023: $2.98Q1 2024: $2.44Q2 2024: $2.31Q3 2024: $2.49Q4 2024: $2.60Q1 2025: $1.36Q2 2025: $1.54Q3 2025: $1.66Q4 2025: $2.37Q1 2026: $4.12Q2 2026: $4.26Q3 2026: $4.38Forward: $5.85
Q4 2023: $2.98Q1 2024: $2.44Q2 2024: $2.31Q3 2024: $2.49Q4 2024: $2.60Q1 2025: $1.36Q2 2025: $1.54Q3 2025: $1.66Q4 2025: $2.37Q1 2026: $4.12Q2 2026: $4.26Q3 2026: $4.38Forward: $5.85
QuarterTTM EPSYoY
Forward$5.85+34%
Q3 2026$4.38+164%
Q2 2026$4.26+177%
Q1 2026$4.12+203%
Q4 2025$2.37-8.8%
Q3 2025$1.66-33%
Q2 2025$1.54-33%
Q1 2025$1.36-44%
Q4 2024$2.60-13%

ALLY's earnings per share have fallen from their peak: $4.38 over the past year, against $8.23 in late 2021.

BAC Earnings Per Share

Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
QuarterTTM EPSYoY
Forward$4.92+17%
Q3 2026$4.19+14%
Q2 2026$4.34+27%
Q1 2026$4.02+20%
Q4 2025$3.81+19%
Q3 2025$3.66+33%
Q2 2025$3.41+20%
Q1 2025$3.35+16%
Q4 2024$3.21+4.2%

BAC has the edge over ALLY on earnings, with more consistent year-over-year improvement.

ALLY Quarterly Revenue

Q4 2023: $2.1BQ1 2024: $2BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.1BQ1 2025: $1.5BQ2 2025: $2.1BQ3 2025: $2.2BQ4 2025: $2.1BQ1 2026: $2.1BQ2 2026: $2.3BQ3 2026: $2.3B
Q4 2023: $2.1BQ1 2024: $2BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.1BQ1 2025: $1.5BQ2 2025: $2.1BQ3 2025: $2.2BQ4 2025: $2.1BQ1 2026: $2.1BQ2 2026: $2.3BQ3 2026: $2.3B
QuarterRevenueYoY
Q3 2026$2.3B+7.6%
Q2 2026$2.3B+9.8%
Q1 2026$2.1B+36%
Q4 2025$2.1B+1.5%
Q3 2025$2.2B+3.1%
Q2 2025$2.1B+4.1%
Q1 2025$1.5B-22%
Q4 2024$2.1B+1.2%

ALLY's revenue has grown year over year for six quarters in a row: $2.3B last quarter, up 7.6% from the same quarter a year ago.

BAC Quarterly Revenue

Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
QuarterRevenueYoY
Q3 2026$30B+6.7%
Q2 2026$31.6B+19%
Q1 2026$30.3B+11%
Q4 2025$31.2B+23%
Q3 2025$28.1B+11%
Q2 2025$26.5B+4.3%
Q1 2025$27.4B+6%
Q4 2024$25.3B+15%

BAC has the edge over ALLY on sales, with more consistent year-over-year improvement.

ALLY Free Cash Flow

Q4 2023: −$17MQ1 2024: $1.3BQ2 2024: $1.6BQ3 2024: $992MQ4 2024: $951MQ1 2025: $940MQ2 2025: $947MQ3 2025: $1.2BQ4 2025: $640MQ1 2026: $1.4BQ2 2026: $1.4BQ3 2026: $1.6B
Q4 2023: −$17MQ1 2024: $1.3BQ2 2024: $1.6BQ3 2024: $992MQ4 2024: $951MQ1 2025: $940MQ2 2025: $947MQ3 2025: $1.2BQ4 2025: $640MQ1 2026: $1.4BQ2 2026: $1.4BQ3 2026: $1.6B
QuarterFree cash flowYoY
Q3 2026$1.6B+33%
Q2 2026$1.4B+43%
Q1 2026$1.4B+46%
Q4 2025$640M-33%
Q3 2025$1.2B+21%
Q2 2025$947M-40%
Q1 2025$940M-30%
Q4 2024$951M+$968M

ALLY has the edge over BAC on cash flow, with more consistent year-over-year improvement.

BAC Free Cash Flow

Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
QuarterFree cash flowYoY
Q3 2026-$6.5B-114%
Q2 2026$29B+$38.2B
Q1 2026$41.8B+$44B
Q4 2025-$22.9B-189%
Q3 2025$46.9B+$84.2B
Q2 2025-$9.1B-150%
Q1 2025-$2.2B+$13.4B
Q4 2024$25.9B-21%

BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.

ALLY Total Shares

Q4 2023: 305MQ1 2024: 308MQ2 2024: 310MQ3 2024: 311MQ4 2024: 310MQ1 2025: 309MQ2 2025: 312MQ3 2025: 314MQ4 2025: 313MQ1 2026: 313MQ2 2026: 311MQ3 2026: 308M
Q4 2023: 305MQ1 2024: 308MQ2 2024: 310MQ3 2024: 311MQ4 2024: 310MQ1 2025: 309MQ2 2025: 312MQ3 2025: 314MQ4 2025: 313MQ1 2026: 313MQ2 2026: 311MQ3 2026: 308M
PeriodChange %Net change
Quarterly-0.9%-2.9M shares
1 year-1.8%-5.7M shares
3 years+0.8%+2.4M shares
5 years-15%-53.7M shares
Available history-22%-87.3M shares

ALLY has 308M diluted shares, down 1.8% from a year ago, with $496M in buybacks over the past year.

BAC Total Shares

Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
PeriodChange %Net change
Quarterly-1%-72M shares
1 year-5.3%-405M shares
3 years-11%-854M shares
5 years-15%-1.3B shares
Available history-24%-2.2B shares

BAC has the edge over ALLY on shareholder dilution, with a more favorable share count trend.

ALLY Net Leverage

Q4 2023: 6.0xQ1 2024: 4.2xQ2 2024: 6.0xQ3 2024: 5.0xQ4 2024: 4.2xQ1 2025: 5.6xQ2 2025: 4.8xQ3 2025: 4.7xQ4 2025: 4.8xQ1 2026: 3.0xQ2 2026: 4.6xQ3 2026: 5.1x
Q4 2023: 6.0xQ1 2024: 4.2xQ2 2024: 6.0xQ3 2024: 5.0xQ4 2024: 4.2xQ1 2025: 5.6xQ2 2025: 4.8xQ3 2025: 4.7xQ4 2025: 4.8xQ1 2026: 3.0xQ2 2026: 4.6xQ3 2026: 5.1x
QuarterNet LeverageStatus
Q3 20265.1xHigh
Q2 20264.6xHigh
Q1 20263.0xElevated
Q4 20254.8xHigh
Q3 20254.7xHigh
Q2 20254.8xHigh
Q1 20255.6xHigh
Q4 20244.2xHigh

ALLY has the edge over BAC on leverage, with a lower net debt burden relative to earnings.

BAC Net Leverage

Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
QuarterNet LeverageStatus
Q3 20266.4xHigh
Q2 20266.7xHigh
Q1 20267.1xHigh
Q4 20257.7xHigh
Q3 20258.3xHigh
Q2 20258.8xHigh
Q1 20258.6xHigh
Q4 20249.0xHigh

BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.

ALLY Weekly Momentum

MetricValueStatus
RSI39.2Neutral
Stochastic21.5Neutral

ALLY's weekly RSI is 39 (neutral) and its Stochastic is 21 (neutral).

BAC Weekly Momentum

MetricValueStatus
RSI37.1Neutral
Stochastic4.9Oversold

BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).

ALLY PE vs Financial Services Sector

MetricALLYSector medianRelative
PE8.7x13x33% below
PE %446319 pts below

ALLY has the edge over BAC on valuation relative to its sector.

BAC PE vs Financial Services Sector

MetricBACSector medianRelative
PE12x13x7.5% below
PE %406323 pts below

BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.

ALLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$38.20.4% below
20 week MA$41.48.2% below
50 week MA$42.19.8% below
100 week MA$39.84.6% below
200 week MA$36.54.2% above

ALLY has fallen below most of its moving averages, though it's still 4.2% above its 200-week average.

BAC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$52.13% below
20 week MA$57.813% below
50 week MA$54.77.7% below
100 week MA$50.50% below
200 week MA$42.519% above

BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.

ALLY Yearly ROI

YearStart priceEnd priceROI
2020$30.6$34.5+13%
2021$34.5$47.6+38%
2022$47.6$23.9-50%
2023$23.9$34.9+46%
2024$34.9$35.7+2.1%
2025$35.7$46.3+30%
2026 YTD$46.3$38.0-18%

ALLY has finished higher in five of the last six years. It's down 18% so far in 2026.

BAC Yearly ROI

YearStart priceEnd priceROI
2020$35.4$30.0-15%
2021$30.0$44.4+48%
2022$44.4$32.5-27%
2023$32.5$33.7+3.7%
2024$33.7$44.3+32%
2025$44.3$56.2+27%
2026 YTD$56.2$50.5-10%

BAC has the edge over ALLY on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key